middle.news
AdAlta Advances CAR-T Deals Amid Funding Challenges and Strategic Shift
3:42am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
AdAlta Advances CAR-T Deals Amid Funding Challenges and Strategic Shift
3:42am on Monday 2nd of June, 2025 AEST
Key Points
Three CAR-T term sheets executed with technical due diligence substantially completed
Internal discovery R&D activities ceased to reduce operating costs
Heads of Agreement with SYNthesis BioVentures for seed funding pending completion
AD-214 antifibrotic drug development continues via third-party partnerships
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Adalta (ASX:1AD)
OPEN ARTICLE